Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4,541 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Different relation between 24-h blood pressure and distensibility at different peripheral arteries. Data from the European Lacidipine Study on Atherosclerosis (ELSA).
Giannattasio C, Failla M, Hennig M, Hollweck R, Laurent S, Mallion JM, Reid J, Safar M, Bond G, Zanchetti A, Mancia G. Giannattasio C, et al. Among authors: reid j. J Hypertens. 2005 Mar;23(3):557-62. doi: 10.1097/01.hjh.0000160212.33232.3e. J Hypertens. 2005. PMID: 15716697 Clinical Trial.
Cardiac structural and functional changes during long-term antihypertensive treatment with lacidipine and atenolol in the European Lacidipine Study on Atherosclerosis (ELSA).
Agabiti-Rosei E, Trimarco B, Muiesan ML, Reid J, Salvetti A, Tang R, Hennig M, Baurecht H, Parati G, Mancia G, Zanchetti A; ELSA Echocardiographic Substudy Group. Agabiti-Rosei E, et al. Among authors: reid j. J Hypertens. 2005 May;23(5):1091-8. doi: 10.1097/01.hjh.0000166852.18463.5e. J Hypertens. 2005. PMID: 15834297 Clinical Trial.
Calcium antagonist lacidipine slows down progression of asymptomatic carotid atherosclerosis: principal results of the European Lacidipine Study on Atherosclerosis (ELSA), a randomized, double-blind, long-term trial.
Zanchetti A, Bond MG, Hennig M, Neiss A, Mancia G, Dal Palù C, Hansson L, Magnani B, Rahn KH, Reid JL, Rodicio J, Safar M, Eckes L, Rizzini P; European Lacidipine Study on Atherosclerosis investigators. Zanchetti A, et al. Among authors: reid jl. Circulation. 2002 Nov 5;106(19):2422-7. doi: 10.1161/01.cir.0000039288.86470.dd. Circulation. 2002. PMID: 12417537 Clinical Trial.
Risk factors associated with alterations in carotid intima-media thickness in hypertension: baseline data from the European Lacidipine Study on Atherosclerosis.
Zanchetti A, Bond MG, Hennig M, Neiss A, Mancia G, Dal Palù C, Hansson L, Magnani B, Rahn KH, Reid J, Rodicio J, Safar M, Eckes L, Ravinetto R. Zanchetti A, et al. Among authors: reid j. J Hypertens. 1998 Jul;16(7):949-61. doi: 10.1097/00004872-199816070-00008. J Hypertens. 1998. PMID: 9794735 Clinical Trial.
The sympathetic nervous system and the metabolic syndrome.
Mancia G, Bousquet P, Elghozi JL, Esler M, Grassi G, Julius S, Reid J, Van Zwieten PA. Mancia G, et al. Among authors: reid j. J Hypertens. 2007 May;25(5):909-20. doi: 10.1097/HJH.0b013e328048d004. J Hypertens. 2007. PMID: 17414649 Review.
Angiotensin II receptor antagonist telmisartan in isolated systolic hypertension (ARAMIS) study: efficacy and safety of telmisartan 20, 40 or 80 mg versus hydrochlorothiazide 12.5 mg or placebo.
Manolis AJ, Reid JL, de Zeeuw D, Murphy MB, Seewaldt-Becker E, Köster J; ARAMIS Study Group. Manolis AJ, et al. Among authors: reid jl. J Hypertens. 2004 May;22(5):1033-7. doi: 10.1097/00004872-200405000-00027. J Hypertens. 2004. PMID: 15097245 Clinical Trial.
4,541 results